ERBB4 and breast carcinoma: These results are consistent with the studies in bladder cancer (Chow et al, 2001) and most of the reports in breast cancer (Knowlden et al, 1998; Suo et al, 1998; 2001; Kew et al, 2000), showing HER4 expression to be a good prognostic indicator.